[TOVX] YoY Quarter Result on 31-Mar-2024 [#Q1]

Stock
[TOVX] Theriva Biologics, Inc.
Announcement Date
07-May-2024
Financial Year
2024
Quarter
31-Mar-2024 [#Q1]
Profit Trend
QoQ- 5.83%
YoY- -15.34%
Quarter Report
TOVX's Result
TOVX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -5,165 -4,808 -4,273 -2,537 -2,990 -3,528 -2,326 14.20%
Tax -4 -330 44 -1 -26 -16 -2,674 -66.14%
NP -5,165 -4,478 -4,317 -2,536 -2,964 -3,512 -2,316 14.28%
Tax Rate - - - - - - - -
Total Cost 5,165 4,478 4,317 2,536 2,964 3,512 2,316 14.28%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -7.53 -7.40 -0.31 -0.28 -1.73 -2.24 -6.30 3.01%
EPS Diluted -7.53 -7.40 -0.31 -0.28 -1.73 -2.24 -6.30 3.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.